FCUV
Focus Universal Inc.
There isn't enough reported data to score FCUV yet.
NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
FCUV Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
FCUV's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
FCUV PE Valuation
FCUV has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
FCUV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect FCUV's losses to grow, with revenue declining.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
FCUV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$32.40 | -$9.73 |
| Q2 2025 | -$18.00 | +$16.67 |
| Q1 2025 | -$18.00 | +$16.67 |
| Q4 2024 | -$19.20 | +$15.47 |
| Q3 2024 | -$22.67 | +$5.33 |
| Q2 2024 | -$34.67 | -$5.34 |
| Q1 2024 | -$34.67 | -$8.00 |
| Q4 2023 | -$34.67 | -$5.34 |
NVDA has the stronger earnings trend. Trailing diluted EPS is down 243% for FCUV versus NVDA up 125%.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA's earnings per share have climbed steadily: $7.91 over the past year, up 125% from the year before, and higher year over year for 13 quarters in a row.
FCUV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $802.4K | +2697% |
| Q2 2026 | $675.2K | +1811% |
| Q1 2026 | $48K | -75% |
| Q4 2025 | $749 | -99% |
| Q3 2025 | $28.7K | -61% |
| Q2 2025 | $35.3K | +79% |
| Q1 2025 | $190.3K | -13% |
| Q4 2024 | $133.2K | -53% |
FCUV's revenue is growing: $802,428 last quarter, up 2697% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -144% | +3970 points |
| Q2 2026 | -230% | +4137 points |
| Q1 2026 | -2651% | -1983 points |
| Q4 2025 | -119974% | -118466 points |
| Q3 2025 | -4114% | -1761 points |
| Q2 2025 | -4367% | +2615 points |
| Q1 2025 | -668% | -66 points |
| Q4 2024 | -1508% | -934 points |
FCUV's operating margin was −144% last quarter, up 3970 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over FCUV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over FCUV on profitability, with a higher operating margin.
FCUV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$853.8K | +$209.3K |
| Q2 2026 | -$7.4M | -$6M |
| Q1 2026 | -$1.1M | +$94.6K |
| Q4 2025 | -$1.4M | -$391.2K |
| Q3 2025 | -$1.1M | +$877.4K |
| Q2 2025 | -$1.4M | -$595.4K |
| Q1 2025 | -$1.2M | -$346.3K |
| Q4 2024 | -$1M | -$77.7K |
FCUV has burned cash in almost every quarter: −$11M over the past year, against −$5M the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over FCUV on cash generation, producing positive trailing cash flow while its opponent burns cash.
FCUV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +36% | +206K shares |
| 1 year | +309% | +582K shares |
| 3 years | +373% | +607K shares |
| 5 years | +401% | +617K shares |
| Available history | +402% | +617K shares |
FCUV has 770,216 diluted shares, up 309% from a year ago, despite $598,857 in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $199,526 |
| Q1 2026 | $154,617 |
| Q4 2025 | $244,714 |
| Q3 2025 | $75,838 |
| Q2 2025 | $29,262 |
| Q1 2025 | $144,575 |
| Q4 2024 | $669,906 |
FCUV spent $598,857 buying back its own shares over the past year, down 35% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over FCUV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
FCUV Net Leverage
FCUV's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
FCUV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.5 | Neutral |
| Stochastic | 2.8 | Oversold |
FCUV's weekly RSI is 39 (neutral) and its Stochastic is 3 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
FCUV PE vs Technology Sector
FCUV has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
FCUV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.64 | 18% below |
| 20 week MA | $5.49 | 45% below |
| 50 week MA | $18.1 | 83% below |
| 100 week MA | $88.7 | 97% below |
| 200 week MA | $298.3 | 99% below |
FCUV is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over FCUV on trend strength, trading above more of its moving averages.
FCUV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,333.3 | $813.3 | -39% |
| 2021 | $813.3 | $2,690.7 | +231% |
| 2022 | $2,690.7 | $1,640.0 | -39% |
| 2023 | $1,640.0 | $584.0 | -64% |
| 2024 | $584.0 | $150.0 | -74% |
| 2025 | $150.0 | $44.8 | -70% |
| 2026 YTD | $44.8 | $3.00 | -93% |
FCUV has finished four years in a row lower, and it's down 93% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over FCUV on returns for 2026, with the stronger performance.